CompletedPhase 2NCT03359356

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Icahn School of Medicine at Mount Sinai
Principal Investigator
Emma Guttman, MD,PhD
Icahn School of Medicine at Mount Sinai
Intervention
Dupilumab(drug)
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
20182020

Study locations (2)

Collaborators

Rockefeller University · Regeneron Pharmaceuticals · Sanofi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03359356 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials